IO Biotech, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
IOBT Company Description
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
IOBT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view IOBT Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of IOBT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IOBT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of IOBT in WallStreetBets Daily Discussion
IOBT News
Recent insights relating to IOBT
CNBC Recommendations
Recent picks made for IOBT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in IOBT
Corporate Flights
Flights by private jets registered to IOBT
Our Analysis